Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Join | Sign in
Home>Videos>This Video
  Videos

Return

Crown Antibodies
Abgent Europe Ltd

At Abgent, the majority of our antibodies are produced in-house, and these antibodies undergo a rigorous validation process by Abgent scientists. However, a number of our most important antibodies meet highly aggressive quality requirements. These products, and many more under review and development, are labeled with a "Crown." Products labeled with a "Crown" meet stringent requirements in terms of specificity, sensitivity, and reproducibility. - All western blots show bands at the correct molecular weight, and any deviation or additional bands have been verified to be due to post translational modifications, isoforms, or cleavage products. - Results are supported by peer reviewed literature and/or by the most relevant bioinformatics sites, i.e. Human Protein Atlas. - Many of these products are validated and optimized in additional applications including immunofluorescence and subcellular localization is verified using peer reviewed literature. - New lots are verified to perform as well or better than the previous lots in each application and species tested.

Request more information
Company product page


Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
A Patient’s Budding Cortex — In A Dish?
Networking neurons thrive in 3-D human “organoid”
Sistemic, RoosterBio Collaborate
This is a collaboration and memorandum of understanding to combine their technologies to advance mesenchymal stem/stromal (MSC) regenerative technology.
Bioresorbable Electronic Stent Could Provide Feedback, Therapy
Researchers have developed and tested a drug releasing electronic stent which could significantly reduce the risk associated with traditional mesh tube stents.
Tiny Spheres Of Human Cells Mimic The Brain
Researchers have figured out how to create spheres of neuronal cells resembling the cerebral cortex, making functional human brain tissue available for the first time to study neuropsychiatric diseases such as autism and schizophrenia.
Study Maps Prenatal Cells
Babies’ sex cells unprotected during pregnancy. Research delivers new data for stem cell scientists to more accurately study infertility.
Bold Steps Toward Engineering New Lungs
ASU researchers are working to improve aspects of lung engineering that may in the future contribute to providing a nearly limitless supply of donor organs, ideally matched to their recipients, or to repairing damaged lungs.
Stem Cell Therapy For Inherited Skin Blistering
Study shows promise for using stem-cell based therapy to treat RDEB.
Inexpensive Technique Developed to Manufacture Nanofibers
Current methods for producing nanofibers are incredibly costly and therefore limit accessibility, this new study opens the door to cheap, mass produced nanofibers.
Designing Better Medical Implants
A team of MIT researchers have discovered a novel method for reducing the typical immune system rejection response when implanting biomedical devices into the body.
UB and Roswell Park receive $1.85M Grant to Launch Stem Cell Research Program
The program will bring together 18 faculty members to advance translation of stem cell breakthroughs into cell therapies.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters